Tofacitinib for the Treatment of Psoriasiform Dermatitis Caused by IL-17 Inhibitors: A Case Report

Psoriasis is a recurring systemic disease that can be treated with biologics to some effect. However, precisely targeting inflammatory mediators may disrupt immune system homeostasis and lead to new conditions. Here, we report a case of psoriasiform dermatitis (PsoD) caused by IL-17 inhibitors (IL-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Nan, Zhong, Lingyuan, Luo, Nana, Wang, Qiuyue, Li, Tianhao, Hao, Pingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204759/
https://www.ncbi.nlm.nih.gov/pubmed/37228572
http://dx.doi.org/10.2147/JIR.S412418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204759/
https://www.ncbi.nlm.nih.gov/pubmed/37228572
http://dx.doi.org/10.2147/JIR.S412418

Ejemplares similares